Not yet recruitingPhase 3NCT07291102

Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

Studying Medulloblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nationwide Children's Hospital
Principal Investigator
Maryam Fouladi, MD
Nationwide Children's Hospital
Intervention
Bridging Chemotherapy(drug)
Enrollment
96 target
Eligibility
5 years · All sexes
Timeline
2026 – 2038

Study locations (2)

Collaborators

German Society of Paediatric Oncology and Hematology (GPOH gGmbH) · Children's of Alabama

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07291102 on ClinicalTrials.gov

Other trials for Medulloblastoma

Additional recruiting or active studies for the same condition.

See all trials for Medulloblastoma →

← Back to all trials